{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:55:05Z","timestamp":1791903305562,"version":"4.3.4"},"reference-count":44,"publisher":"American Society of Hematology","issue":"19","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10,13]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Hematopoietic stem cell (HSC) transplantation is a common treatment for many blood disorders and can be a lifesaving therapy for patients with leukemias, lymphomas, and multiple myeloma. Umbilical cord blood (UCB) serves as a valuable source of hematopoietic stem and progenitor cells (HSPCs) for transplantation, particularly for patients lacking a matched donor. However, the limited number of repopulating cells in UCB units restricts its clinical utility. Our prior studies showed that the genetic deletion of the polycomb repressive complex 2 (PRC2) cofactor Jarid2 in mouse multipotent progenitors (MPPs) conveyed ectopic self-renewal capacity. Here, we hypothesized that the function of human HSPCs could be enhanced through JARID2 inhibition. In this study, we demonstrate that both constitutive and transient knockdown (KD) of JARID2 increases the number and enhances the functionality of human HSPCs both in vitro and in vivo. This phenotype was distinct from the inhibition of EZH2 in UCB cells, suggesting that the mechanism was independent of the PRC2 cofactor activity of JARID2. Mechanistically, JARID2 KD promotes a quiescent, long-term self-renewal gene expression program governed by STAT1 upregulation and characterized by an MHC class II immunophenotype. Analogous to mice, these mechanisms conferred HSC-like potential to human MPPs in vivo. Taken together, these findings highlight JARID2 inhibition as a novel and reversible approach to expand functional UCB-derived HSPCs ex vivo, potentially improving access to stem cell transplantation for a wider patient population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025019220","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T01:28:52Z","timestamp":1784770132000},"page":"6474-6488","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["<i>JARID2<\/i>\n                    inhibition reprograms human hematopoietic progenitor cells to enhance bone marrow transplantation"],"prefix":"10.1182","volume":"10","author":[{"given":"Wentao","family":"Han","sequence":"first","affiliation":[{"name":"1Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Bjeije","sequence":"additional","affiliation":[{"name":"1Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamza","family":"Celik","sequence":"additional","affiliation":[{"name":"1Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1091-0564","authenticated-orcid":false,"given":"Michael","family":"Rettig","sequence":"additional","affiliation":[{"name":"1Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Issa","sequence":"additional","affiliation":[{"name":"1Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7698-3267","authenticated-orcid":false,"given":"Andrew L.","family":"Young","sequence":"additional","affiliation":[{"name":"2Division of Hematology, Department of Medicine, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Li","sequence":"additional","affiliation":[{"name":"3Department of Pediatrics, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4889-4643","authenticated-orcid":false,"given":"Infencia Xavier","family":"Raj","sequence":"additional","affiliation":[{"name":"1Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine R.","family":"Zhang","sequence":"additional","affiliation":[{"name":"1Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aishwarya","family":"Krishnan","sequence":"additional","affiliation":[{"name":"1Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0277-1557","authenticated-orcid":false,"given":"Tyler M.","family":"Parsons","sequence":"additional","affiliation":[{"name":"1Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8375-8699","authenticated-orcid":false,"given":"Samantha C.","family":"Burkart","sequence":"additional","affiliation":[{"name":"1Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Arand","sequence":"additional","affiliation":[{"name":"1Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yang","sequence":"additional","affiliation":[{"name":"3Department of Pediatrics, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0766-4200","authenticated-orcid":false,"given":"Jeffrey A.","family":"Magee","sequence":"additional","affiliation":[{"name":"3Department of Pediatrics, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4669-8814","authenticated-orcid":false,"given":"Grant A.","family":"Challen","sequence":"additional","affiliation":[{"name":"1Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"issue":"11","key":"2026101310413630300_bib1","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/j.bbmt.2015.07.032","article-title":"Indications for autologous and allogeneic hematopoietic cell transplantation: guidelines from the American Society for Blood and Marrow Transplantation","volume":"21","author":"Majhail","year":"2015","journal-title":"Biol Blood Marrow Transpl"},{"issue":"4","key":"2026101310413630300_bib2","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ccm.2017.07.001","article-title":"Overview of hematopoietic cell transplantation for the treatment of hematologic malignancies","volume":"38","author":"Singh","year":"2017","journal-title":"Clin Chest Med"},{"issue":"5-6","key":"2026101310413630300_bib3","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3109\/10428199609054857","article-title":"Graft-versus-leukemia effect and its clinical implications","volume":"23","author":"Imamura","year":"1996","journal-title":"Leuk Lymphoma"},{"issue":"12","key":"2026101310413630300_bib4","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1182\/blood.2019001212","article-title":"Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP\/CIBMTR","volume":"134","author":"Dehn","year":"2019","journal-title":"Blood"},{"issue":"4","key":"2026101310413630300_bib5","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1056\/NEJMsa1311707","article-title":"HLA match likelihoods for hematopoietic stem-cell grafts in the US Registry","volume":"371","author":"Gragert","year":"2014","journal-title":"N Engl J Med"},{"issue":"9577","key":"2026101310413630300_bib6","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/S0140-6736(07)60915-5","article-title":"Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study","volume":"369","author":"Eapen","year":"2007","journal-title":"Lancet"},{"issue":"25","key":"2026101310413630300_bib7","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1056\/NEJM200006223422501","article-title":"Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources","volume":"342","author":"Rocha","year":"2000","journal-title":"N Engl J Med"},{"issue":"1","key":"2026101310413630300_bib8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1040-8428(03)00092-1","article-title":"Umbilical cord blood transplantation: current practice and future innovations","volume":"48","author":"Barker","year":"2003","journal-title":"Crit Rev Oncol Hematol"},{"issue":"11","key":"2026101310413630300_bib9","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.bbmt.2010.08.011","article-title":"Availability of cord blood extends allogeneic hematopoietic stem cell transplant access to racial and ethnic minorities","volume":"16","author":"Barker","year":"2010","journal-title":"Biol Blood Marrow Transpl"},{"issue":"5","key":"2026101310413630300_bib10","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/stem.170286","article-title":"Comparison of hematopoietic activities of human bone marrow and umbilical cord blood CD34 positive and negative cells","volume":"17","author":"Kim","year":"1999","journal-title":"Stem Cells"},{"key":"2026101310413630300_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.17.00078","article-title":"Graft-versus-leukemia effect of allogeneic stem-cell transplantation and minimal residual disease in patients with acute myeloid leukemia in first complete remission","volume":"1","author":"Versluis","year":"2017","journal-title":"JCO Precis Oncol"},{"issue":"4","key":"2026101310413630300_bib12","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.bbmt.2018.10.016","article-title":"Single-unit versus double-unit umbilical cord blood transplantation in children and young adults with residual leukemic disease","volume":"25","author":"Balligand","year":"2019","journal-title":"Biol Blood Marrow Transpl"},{"issue":"5997","key":"2026101310413630300_bib13","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1126\/science.1191536","article-title":"Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells","volume":"329","author":"Boitano","year":"2010","journal-title":"Science"},{"issue":"6203","key":"2026101310413630300_bib14","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1126\/science.1256337","article-title":"Cord blood expansion. Pyrimidoindole derivatives are agonists of human hematopoietic stem cell self-renewal","volume":"345","author":"Fares","year":"2014","journal-title":"Science"},{"issue":"3","key":"2026101310413630300_bib15","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/nm.4477","article-title":"Antagonism of PPAR-gamma signaling expands human hematopoietic stem and progenitor cells by enhancing glycolysis","volume":"24","author":"Guo","year":"2018","journal-title":"Nat Med"},{"issue":"22","key":"2026101310413630300_bib16","doi-asserted-by":"crossref","first-page":"5444","DOI":"10.1182\/blood-2009-01-201335","article-title":"Prostaglandin E-2 enhances hematopoietic stem cell homing, survival, and proliferation","volume":"113","author":"Hoggatt","year":"2009","journal-title":"Blood"},{"issue":"2","key":"2026101310413630300_bib17","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.bcmd.2006.10.159","article-title":"A high-throughput chemical genetic screen in zebrafish establishes that prostaglandin E2 is a potent regulator of hematopoietic stem cell formation","volume":"38","author":"North","year":"2007","journal-title":"Blood Cells Mol Dis"},{"issue":"7147","key":"2026101310413630300_bib18","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/nature05883","article-title":"Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis","volume":"447","author":"North","year":"2007","journal-title":"Nature"},{"issue":"1","key":"2026101310413630300_bib19","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.stem.2015.10.004","article-title":"Phase I\/II trial of StemRegenin-1 expanded umbilical cord blood hematopoietic stem cells supports testing as a stand-alone graft","volume":"18","author":"Wagner","year":"2016","journal-title":"Cell Stem Cell"},{"issue":"17","key":"2026101310413630300_bib20","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1182\/blood-2013-05-503177","article-title":"Prostaglandin-modulated umbilical cord blood hematopoietic stem cell transplantation","volume":"122","author":"Cutler","year":"2013","journal-title":"Blood"},{"issue":"1","key":"2026101310413630300_bib21","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41392-023-01342-6","article-title":"Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"2026101310413630300_bib22","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.ccell.2018.10.008","article-title":"JARID2 functions as a tumor suppressor in myeloid neoplasms by repressing self-renewal in hematopoietic progenitor cells","volume":"34","author":"Celik","year":"2018","journal-title":"Cancer Cell"},{"issue":"12","key":"2026101310413630300_bib23","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1182\/blood-2014-10-603969","article-title":"Jarid2 regulates hematopoietic stem cell function by acting with polycomb repressive complex 2","volume":"125","author":"Kinkel","year":"2015","journal-title":"Blood"},{"issue":"6","key":"2026101310413630300_bib24","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.celrep.2013.11.020","article-title":"An optimized microRNA backbone for effective single-copy RNAi","volume":"5","author":"Fellmann","year":"2013","journal-title":"Cell Rep"},{"key":"2026101310413630300_bib25","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.omtm.2019.05.015","article-title":"Enhancing lentiviral and alpharetroviral transduction of human hematopoietic stem cells for clinical application","volume":"14","author":"Schott","year":"2019","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"3","key":"2026101310413630300_bib26","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/ajh.22257","article-title":"Frequent deletions of JARID2 in leukemic transformation of chronic myeloid malignancies","volume":"87","author":"Puda","year":"2012","journal-title":"Am J Hematol"},{"issue":"11","key":"2026101310413630300_bib27","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/ajh.23309","article-title":"Clinical significance of genetic aberrations in secondary acute myeloid leukemia","volume":"87","author":"Milosevic","year":"2012","journal-title":"Am J Hematol"},{"issue":"50","key":"2026101310413630300_bib28","doi-asserted-by":"crossref","first-page":"E5401","DOI":"10.1073\/pnas.1407792111","article-title":"Genomic and functional analysis of leukemic transformation of myeloproliferative neoplasms","volume":"111","author":"Rampal","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"22","key":"2026101310413630300_bib29","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","article-title":"Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia","volume":"368","author":"Ley","year":"2013","journal-title":"N Engl J Med"},{"issue":"1","key":"2026101310413630300_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.stem.2020.12.002","article-title":"UM171 preserves epigenetic marks that are reduced in ex vivo culture of human HSCs via potentiation of the CLR3-KBTBD4 complex","volume":"28","author":"Chagraoui","year":"2021","journal-title":"Cell Stem Cell"},{"issue":"19","key":"2026101310413630300_bib31","doi-asserted-by":"crossref","first-page":"5717","DOI":"10.1182\/bloodadvances.2023010599","article-title":"Improved outcomes of UM171-expanded cord blood transplantation compared with other graft sources: real-world evidence","volume":"7","author":"Cohen","year":"2023","journal-title":"Blood Adv"},{"issue":"23","key":"2026101310413630300_bib32","doi-asserted-by":"crossref","first-page":"e124928","DOI":"10.1172\/jci.insight.124928","article-title":"Human bone marrow assessment by single-cell RNA sequencing, mass cytometry, and flow cytometry","volume":"3","author":"Oetjen","year":"2018","journal-title":"JCI Insight"},{"issue":"12","key":"2026101310413630300_bib33","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/s41587-019-0332-7","article-title":"Single-cell multiomic analysis identifies regulatory programs in mixed-phenotype acute leukemia","volume":"37","author":"Granja","year":"2019","journal-title":"Nat Biotechnol"},{"issue":"6","key":"2026101310413630300_bib34","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/ncb2065","article-title":"Jarid2 is a PRC2 component in embryonic stem cells required for multi-lineage differentiation and recruitment of PRC1 and RNA polymerase II to developmental regulators","volume":"12","author":"Landeira","year":"2010","journal-title":"Nat Cell Biol"},{"issue":"7286","key":"2026101310413630300_bib35","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nature08788","article-title":"JARID2 regulates binding of the Polycomb repressive complex 2 to target genes in ES cells","volume":"464","author":"Pasini","year":"2010","journal-title":"Nature"},{"issue":"6039","key":"2026101310413630300_bib36","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1126\/science.1201219","article-title":"Isolation of single human hematopoietic stem cells capable of long-term multilineage engraftment","volume":"333","author":"Notta","year":"2011","journal-title":"Science"},{"issue":"13","key":"2026101310413630300_bib37","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1182\/blood-2015-07-660670","article-title":"Human hematopoietic stem cells from mobilized peripheral blood can be purified based on CD49f integrin expression","volume":"126","author":"Huntsman","year":"2015","journal-title":"Blood"},{"key":"2026101310413630300_bib38","doi-asserted-by":"crossref","first-page":"104788","DOI":"10.1016\/j.exphem.2025.104788","article-title":"Hematopoietic stem cells in human fetal liver selectively express CD49f","volume":"149","author":"MacAldaz","year":"2025","journal-title":"Exp Hematol"},{"issue":"5","key":"2026101310413630300_bib39","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1600-0609.1997.tb01693.x","article-title":"Characterization and phenotypic analysis of differentiating CD34+ human bone marrow cells in liquid culture","volume":"59","author":"Gross","year":"1997","journal-title":"Eur J Haematol"},{"issue":"3","key":"2026101310413630300_bib40","doi-asserted-by":"crossref","first-page":"102793","DOI":"10.1016\/j.stemcr.2026.102793","article-title":"Comparison with Ezh2 reveals the PRC2-dependent functions of Jarid2 in hematopoietic stem Cell lineage commitment","volume":"21","author":"Bjeije","year":"2026","journal-title":"Stem Cell Rep"},{"issue":"8016","key":"2026101310413630300_bib42","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41586-024-07478-x","article-title":"MYCT1 controls environmental sensing in human haematopoietic stem cells","volume":"630","author":"Aguade-Gorgorio","year":"2024","journal-title":"Nature"},{"issue":"7786","key":"2026101310413630300_bib41","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41586-019-1790-2","article-title":"MLLT3 governs human haematopoietic stem-cell self-renewal and engraftment","volume":"576","author":"Calvanese","year":"2019","journal-title":"Nature"},{"issue":"5","key":"2026101310413630300_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.stem.2022.04.007","article-title":"Antigen presentation safeguards the integrity of the hematopoietic stem cell pool","volume":"29","author":"Hernandez-Malmierca","year":"2022","journal-title":"Cell Stem Cell"},{"issue":"14","key":"2026101310413630300_bib44","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1182\/blood.2021014009","article-title":"STAT1 is essential for HSC function and maintains MHCIIhi stem cells that resist myeloablation and neoplastic expansion","volume":"140","author":"Li","year":"2022","journal-title":"Blood"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/19\/6474\/2590981\/blooda_adv-2025-019220-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/19\/6474\/2590981\/blooda_adv-2025-019220-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:41:46Z","timestamp":1791902506000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/19\/6474\/569801\/JARID2-inhibition-reprograms-human-hematopoietic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":44,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2026,10,13]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025019220","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10,13]]},"published":{"date-parts":[[2026,9,25]]}}}